Open Access iconOpen Access

ARTICLE

crossmark

Long Term Follow-Up of Ebstein’s Anomaly—What to Expect in Adult Life?

by Tânia Branco Mano1,*, João Ferreira Reis1, Ana Figueiredo Agapito1, André Monteiro1, Mário Oliveira1, Luísa Moura Branco1, José Fragata2, Fátima Pinto3, Rui Cruz Ferreira1, Lídia de Sousa1

1 Department of Cardiology, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Lisbon, 1169-024, Portugal
2 Department of Cardiothoracic Surgery, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Lisbon, 1169-024, Portugal
3 Department of Paediatric Cardiology, Hospital de Santa Marta, Centro Hospitalar Universitário de Lisboa Central, Lisbon, 1169-024, Portugal

* Corresponding Author: Tânia Branco Mano. Email: email

Congenital Heart Disease 2020, 15(3), 153-162. https://doi.org/10.32604/CHD.2020.011500

Abstract

Introduction: Due to the low prevalence and wide variation of severity of Ebstein’s Anomaly (EA), long-term follow-up data are scarce. The aim was to evaluate the long-term outcome of an adult population with EA. Methods: Retrospective analysis of EA adults followed in the past 42 years in a tertiary congenital heart disease outpatient clinic. Predictors of complications and mortality were assessed. Results: We studied 53 patients: 53% females, mean age 46 ± 19 years, 36% cyanotic, 55% diagnosed at adult age. Tricuspid regurgitation was moderate or severe in 33% and 46%, respectively, and during follow-up (mean 12 ± 10 years) 11 patients had right ventricular dysfunction. We found an association between New York Heart Association class and cyanosis (p = 0.041) and severity of tricuspid regurgitation (p = 0.02). The most frequent symptom was palpitations (57%), with 29 patients exhibiting rhythm disturbances (62% supraventricular tachycardia). Thromboembolic events were found in 23% and were associated with atrial septal defect or patent foramen ovale (p = 0.017) and arrhythmia diagnosis (p = 0.011). Nine patients required tricuspid valve surgery and two underwent cardiac transplantation. In 25 pregnancies, 48% developed fetal complications. Total of 14 deaths (2.4 deaths per 10 patients-years) occurring at a mean age of 49 ± 18 years, of cardiac cause in more than half of the cases and 29% of sudden death. No significant differences were found in the mortality rate of patients presenting with severe tricuspid regurgitation, with or without surgical management. Conclusion: Ebstein’s Anomaly is often diagnosed in adulthood. It is accompanied by high morbidity, especially arrhythmias, and non-negligible mortality with relevance in assessing the risk of sudden death.

Keywords


Cite This Article

APA Style
Mano, T.B., Reis, J.F., Agapito, A.F., Monteiro, A., Oliveira, M. et al. (2020). Long term follow-up of ebstein’s anomaly—what to expect in adult life?. Congenital Heart Disease, 15(3), 153-162. https://doi.org/10.32604/CHD.2020.011500
Vancouver Style
Mano TB, Reis JF, Agapito AF, Monteiro A, Oliveira M, Branco LM, et al. Long term follow-up of ebstein’s anomaly—what to expect in adult life?. Congeni Heart Dis. 2020;15(3):153-162 https://doi.org/10.32604/CHD.2020.011500
IEEE Style
T. B. Mano et al., “Long Term Follow-Up of Ebstein’s Anomaly—What to Expect in Adult Life?,” Congeni. Heart Dis., vol. 15, no. 3, pp. 153-162, 2020. https://doi.org/10.32604/CHD.2020.011500



cc Copyright © 2020 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 3021

    View

  • 1723

    Download

  • 0

    Like

Share Link